← Nootropic Dictionary

Cholinesterase Inhibitor

Galantamine

A compound that enhances acetylcholine levels by inhibiting its breakdown, supporting memory and cognition.

Evidence gradeCross-checked · High
A
WeakModerateStrong
4.1/ 5 rating

KÖGN Health grades Galantamine as A (Strong evidence) and rates it 4.1 out of 5.

Last reviewed · June 2026

CategorySynthetic · Cholinesterase Inhibitor
AvailabilityPrescription

Primary effects

  • Improved memory
  • Enhanced cognition
  • Increased focus

How it works

Inhibits acetylcholinesterase, increasing acetylcholine availability in the brain.

Overview

Galantamine is used clinically in the treatment of cognitive decline, particularly in Alzheimer’s disease. Its mechanism of action makes it a potent enhancer of memory and learning. Due to its strength, it should be used with caution and typically under guidance. It is not generally considered a beginner nootropic but can be highly effective in targeted applications.

The evidence

Galantamine is a prescription cholinesterase inhibitor (and nicotinic modulator) licensed for Alzheimer's disease. Cochrane and comparative meta-analyses show a modest benefit on cognition and daily function in dementia, similar to other drugs of its class. It is popular in some circles for lucid dreaming, but there is no good evidence it enhances cognition in healthy people.

Safety & side effects

Cholinergic effects dominate: nausea, vomiting, diarrhoea, a slowed heart rate, and disturbed sleep, particularly when starting or increasing the dose.

Who should avoid it

Prescription-only — not for self-dosing. It is risky with heart-rhythm problems, asthma or COPD, and active peptic ulcers, and should not be combined with other cholinergic or anticholinergic drugs without medical advice. Use only under a prescriber.

References

Related ingredients

Graded entries that target the same cognitive goals.

Categories

Synthetic NootropicsMemory & LearningCholinergics (Acetylcholine Support)Acute Performance NootropicsPrescription-BasedHigh Evidence

Draft — the dose, safety and evidence notes on this entry were prepared from the published literature and are pending editorial and clinical review.

Educational information, not medical advice. The evidence grade is KÖGN’s editorial assessment of published research, not a health claim. Speak to a qualified clinician before changing what you take.